Long-Term Use Of Hormonal Contraceptives Leads To Glioma

Long-Term Use Of Hormonal Contraceptives Leads To Glioma.
The peril for developing a atypical fashion of intelligence cancer known as glioma appears to go up with long-term use of hormonal contraceptives such as the Pill, fresh Danish analyse suggests. Women under 50 with a glioma "were 90 percent more favoured to have been using hormonal contraceptives for five years or more, compared with women from the blanket denizens with no history of genius tumor," said study leader Dr David Gaist antehealth.com. However, the Danish scrutiny couldn't be shown cause-and-effect, and Gaist stressed that the findings "need to be put in context" for women because "glioma is very rare".

How rare? Only five out of every 100000 Danish women between the ages of 15 and 49 show the influence each year, according to Gaist, a professor of neurology at Odense University Hospital. He said that leader includes women who grip contraceptives such as the beginning mastery pill. So, "an overall risk-benefit computation favors continued use of hormonal contraceptives". The findings were published online in the British Journal of Clinical Pharmacology.

In the study, Gaist's gang looked at domination statistics on all Danish women between the ages of 15 and 49 who had developed a glioma between 2000 and 2009. In all, investigators identified 317 glioma cases, all whom nearly 60 percent had employed a contraceptive at some point. They then compared them to more than 2100 glioma-free women of almost identical ages, about half of whom had in use contraceptives. Use of the Pill or other hormonal contraceptive did appear to lump up the hazard for glioma, the researchers reported, and the jeopardy seemed to gain with the duration of use.

A New Prostate Cancers Treatment Strategy

A New Prostate Cancers Treatment Strategy.
Conventional understanding has it that steep levels of testosterone succour prostate cancers grow. However, a new, trivial swotting suggests that a treatment strategy called bipolar androgen psychoanalysis - where patients exchange between low and high levels of testosterone - might enact prostate tumors more responsive to emblem hormonal therapy. As the researchers explained, the beginning treatment for advanced prostate cancer is hormonal therapy, which lowers levels of testosterone to block the tumor from growing fav-store.net. But there's a problem: Prostate cancer cells inevitably whip the analysis by increasing their adeptness to suck up any leftover testosterone in the body.

The new procedure forces the tumor to respond again to higher testosterone levels, serving to reverse its resistance to insigne therapy, the researchers say. If confirmed in several unending larger trials, "this could incline to a new treatment approach" for prostate cancers that have grown stubborn to hormonal therapy, said pilot researcher Dr Michael Schweizer, an helper professor of oncology at the University of Washington School of Medicine in Seattle.

So "It needs to be stressed that bipolar androgen cure is not likely for adoption into conventional clinical practice, since these studies have not been completed. The communication was published Jan 7, 2015 in the annual Science Translational Medicine. For the study, 16 men with hormone therapy-resistant prostate cancer received bipolar androgen therapy. Of these patients, seven had their cancer go into remission. In four men, tumors shrank, and in one man, tumors disappeared completely, the researchers report.